Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Claire Mazumdar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- SVF Pauling (Cayman) Ltd - $116.40M of RLAY open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $40.00M of BCAX open-market activity in the last 12 months
- Thomas Catinazzo - $4.83M of RLAY open-market activity in the last 12 months
- Ryan Cohlhepp - $4.20M of BCAX open-market activity in the last 12 months
- Ivan Hyep - $3.07M of BCAX open-market activity in the last 12 months
- Sanjiv Patel - $2.70M of RLAY open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Claire Mazumdar?
Claire Mazumdar is a corporate insider, tracked as Chief Executive Officer, Director of Bicara Therapeutics Inc. (BCAX). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Claire Mazumdar submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Has Claire Mazumdar been buying or selling stock?
Recorded transactions: 0 open-market purchases and 17 open-market sales ($4.06M) across all tracked filings.
Where can I see all of Claire Mazumdar's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Claire Mazumdar and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
